I didn't have to worry about it, and not have to feel like someone was looking at me sideways." Appearing on the 3rd Hour of TODAY, Williams said that she wanted to come forward because "a lot of people are actually on GLP-1s but don't really want to talk about it, don't want to say it." "That's why I feel like my story is so important because I'm so active," she adds
As with any potent herb, cycling on and off is advised to maintain its efficacy and minimize any adaptation by the body
Obesity, vol 32(6): 1163-1168
Most obesity medicine specialists recommend sequential monotherapy or waiting for robust clinical trial data before endorsing dual use
The growing demand for more effective, long-term treatments for obesity, diabetes, and cardiovascular health has driven the rapid adoption of GLP-1 receptor agonists